Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism

David Kahne, Luminita (Alina) Tudorica, Alice Borella, Lee Shapiro, Fabian Johnstone, Wei Huang, Patricia M. Whitaker-Azmitia

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Autism is classified as a pervasive developmental disorder, with several cardinal features including sensory disturbances, obsessive-compulsive-like behavior, lack of bonding to caregivers and motor disturbances. To date, there is a lack of an animal model of the disease. The current work is aimed at producing such a model by treating developing rat pups with a serotonergic agonist, 5-methoxytryptamine (5-MT; 1 mg/kg) during development (from gestational age 12 days to postnatal day 20), thus mimicking one of the hallmark neurochemical features of the illness - increases in the neurotransmitter, serotonin. Animals were then tested in behavioral paradigms that may resemble the human illness. Treated rat pups were found to be overreactive to auditory or tactile sensory stimuli, to display changes in the negative geotaxic test of motor development, to show lack of separation-induced vocalizations when their dam was removed and to show decreased alternation in the spontaneous alternation task. As well, the animals showed metabolic abnormalities in the brain using in vivo proton magnetic resonance spectroscopy, which are consistent with those observed in autistic children. In summary, the model we are proposing shows some of the behavioral and metabolic features of autism, as well as being produced through alteration of a neurochemical system known to be altered in autism.

Original languageEnglish (US)
Pages (from-to)403-410
Number of pages8
JournalPhysiology and Behavior
Volume75
Issue number3
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Autistic Disorder
Magnetic Resonance Spectroscopy
5-Methoxytryptamine
Compulsive Behavior
Animal Disease Models
Serotonin Receptor Agonists
Touch
Caregivers
Gestational Age
Neurotransmitter Agents
Serotonin
Brain

Keywords

  • Auditory
  • Autism
  • Magnetic resonance spectroscopy
  • Negative geotaxis
  • Serotonin
  • Spontaneous alternation
  • Tactile
  • Ultrasonic vocalization

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Physiology (medical)

Cite this

Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. / Kahne, David; Tudorica, Luminita (Alina); Borella, Alice; Shapiro, Lee; Johnstone, Fabian; Huang, Wei; Whitaker-Azmitia, Patricia M.

In: Physiology and Behavior, Vol. 75, No. 3, 2002, p. 403-410.

Research output: Contribution to journalArticle

Kahne, David ; Tudorica, Luminita (Alina) ; Borella, Alice ; Shapiro, Lee ; Johnstone, Fabian ; Huang, Wei ; Whitaker-Azmitia, Patricia M. / Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. In: Physiology and Behavior. 2002 ; Vol. 75, No. 3. pp. 403-410.
@article{86d9fea629a3462ba9b6586cfc24aa46,
title = "Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism",
abstract = "Autism is classified as a pervasive developmental disorder, with several cardinal features including sensory disturbances, obsessive-compulsive-like behavior, lack of bonding to caregivers and motor disturbances. To date, there is a lack of an animal model of the disease. The current work is aimed at producing such a model by treating developing rat pups with a serotonergic agonist, 5-methoxytryptamine (5-MT; 1 mg/kg) during development (from gestational age 12 days to postnatal day 20), thus mimicking one of the hallmark neurochemical features of the illness - increases in the neurotransmitter, serotonin. Animals were then tested in behavioral paradigms that may resemble the human illness. Treated rat pups were found to be overreactive to auditory or tactile sensory stimuli, to display changes in the negative geotaxic test of motor development, to show lack of separation-induced vocalizations when their dam was removed and to show decreased alternation in the spontaneous alternation task. As well, the animals showed metabolic abnormalities in the brain using in vivo proton magnetic resonance spectroscopy, which are consistent with those observed in autistic children. In summary, the model we are proposing shows some of the behavioral and metabolic features of autism, as well as being produced through alteration of a neurochemical system known to be altered in autism.",
keywords = "Auditory, Autism, Magnetic resonance spectroscopy, Negative geotaxis, Serotonin, Spontaneous alternation, Tactile, Ultrasonic vocalization",
author = "David Kahne and Tudorica, {Luminita (Alina)} and Alice Borella and Lee Shapiro and Fabian Johnstone and Wei Huang and Whitaker-Azmitia, {Patricia M.}",
year = "2002",
doi = "10.1016/S0031-9384(01)00673-4",
language = "English (US)",
volume = "75",
pages = "403--410",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism

AU - Kahne, David

AU - Tudorica, Luminita (Alina)

AU - Borella, Alice

AU - Shapiro, Lee

AU - Johnstone, Fabian

AU - Huang, Wei

AU - Whitaker-Azmitia, Patricia M.

PY - 2002

Y1 - 2002

N2 - Autism is classified as a pervasive developmental disorder, with several cardinal features including sensory disturbances, obsessive-compulsive-like behavior, lack of bonding to caregivers and motor disturbances. To date, there is a lack of an animal model of the disease. The current work is aimed at producing such a model by treating developing rat pups with a serotonergic agonist, 5-methoxytryptamine (5-MT; 1 mg/kg) during development (from gestational age 12 days to postnatal day 20), thus mimicking one of the hallmark neurochemical features of the illness - increases in the neurotransmitter, serotonin. Animals were then tested in behavioral paradigms that may resemble the human illness. Treated rat pups were found to be overreactive to auditory or tactile sensory stimuli, to display changes in the negative geotaxic test of motor development, to show lack of separation-induced vocalizations when their dam was removed and to show decreased alternation in the spontaneous alternation task. As well, the animals showed metabolic abnormalities in the brain using in vivo proton magnetic resonance spectroscopy, which are consistent with those observed in autistic children. In summary, the model we are proposing shows some of the behavioral and metabolic features of autism, as well as being produced through alteration of a neurochemical system known to be altered in autism.

AB - Autism is classified as a pervasive developmental disorder, with several cardinal features including sensory disturbances, obsessive-compulsive-like behavior, lack of bonding to caregivers and motor disturbances. To date, there is a lack of an animal model of the disease. The current work is aimed at producing such a model by treating developing rat pups with a serotonergic agonist, 5-methoxytryptamine (5-MT; 1 mg/kg) during development (from gestational age 12 days to postnatal day 20), thus mimicking one of the hallmark neurochemical features of the illness - increases in the neurotransmitter, serotonin. Animals were then tested in behavioral paradigms that may resemble the human illness. Treated rat pups were found to be overreactive to auditory or tactile sensory stimuli, to display changes in the negative geotaxic test of motor development, to show lack of separation-induced vocalizations when their dam was removed and to show decreased alternation in the spontaneous alternation task. As well, the animals showed metabolic abnormalities in the brain using in vivo proton magnetic resonance spectroscopy, which are consistent with those observed in autistic children. In summary, the model we are proposing shows some of the behavioral and metabolic features of autism, as well as being produced through alteration of a neurochemical system known to be altered in autism.

KW - Auditory

KW - Autism

KW - Magnetic resonance spectroscopy

KW - Negative geotaxis

KW - Serotonin

KW - Spontaneous alternation

KW - Tactile

KW - Ultrasonic vocalization

UR - http://www.scopus.com/inward/record.url?scp=0036122464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036122464&partnerID=8YFLogxK

U2 - 10.1016/S0031-9384(01)00673-4

DO - 10.1016/S0031-9384(01)00673-4

M3 - Article

C2 - 11897268

AN - SCOPUS:0036122464

VL - 75

SP - 403

EP - 410

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 3

ER -